Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Statement re Share Consolidation

30 Sep 2014 15:11

RNS Number : 0490T
Maven Income & Growth VCT 4 PLC
30 September 2014
 

MAVEN INCOME AND GROWTH VCT 4 PLC

 

Completion of Share Consolidation

 

30 September 2014

 

This announcement is made by Maven Income and Growth VCT 4 plc ("the Company") in connection with the consolidation ("Share Consolidation") of the C ordinary shares of 10p each in the capital of the Company ("C Shares") into the ordinary shares of 10p each in the capital of the Company ("Ordinary Shares").

 

The Board of the Company is pleased to advise that the Share Consolidation has today been implemented, in accordance with the articles of association of the Company, as follows:

 

· 3,863,876 C Shares have been redesignated as 3,077,827 Ordinary Shares (based on a conversion ratio of 0.796847454551093 per holding of C Shares and rounded down to the nearest whole share); and

 

· the balance of the C Shares held by a C Shareholder which were not redesignated as Ordinary Shares were redesignated as deferred shares of 10p each, all of which have been bought back by the Company for an aggregate price of 1p and cancelled.

 

As a result of the above, the issued share capital of the Company now forms one class of share, Ordinary Shares, 32,499,188 of which are in issue. No Ordinary Shares are held in treasury by the Company.

 

Application has been made to the UKLA and the London Stock Exchange for amendments to the listing of the Ordinary Shares and C Shares to reflect the Share Consolidation.

 

Shareholders who hold their existing C Shares in certificated form will receive replacement certificates in respect of the Ordinary Shares arising from the Share Consolidation and existing share certificates in respect of C Shares will no longer be valid. Shareholders who hold their C Shares in CREST will have their CREST accounts updated.

 

For further enquiries please contact:

 

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRZBLFXZKFFBBB
Date   Source Headline
20th May 202610:12 amRNSAdmission of Further Securities to Trading
15th May 202610:45 amRNSDirector/PDMR Shareholding
15th May 202610:41 amRNSIssue of Equity - Dividend Investment Scheme
14th May 20265:22 pmRNSTransaction in Own Shares
12th May 20263:37 pmRNSUnaudited NAV - Dividend Investment Scheme
7th May 20261:45 pmRNSResult of AGM
30th Apr 202610:58 amRNSAdmission of Further Securities to Trading
29th Apr 202612:29 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:27 amRNSAdmission of Further Securities to Trading
14th Apr 202611:09 amRNSIssue of Equity
10th Apr 202612:02 pmRNSUnaudited Net Asset Value
8th Apr 20269:33 amRNSAdmission of Further Securities to Trading
25th Mar 20263:51 pmRNSTransaction in Own Shares
25th Mar 202610:55 amRNSAdmission of Further Securities to Trading
24th Mar 202612:11 pmRNSIssue of Equity
19th Mar 20264:21 pmRNSUnaudited NAV and Proposed Final Dividend
18th Feb 20264:58 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202610:54 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:07 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:52 amRNSDirector/PDMR Shareholding
16th Jan 20269:44 amRNSIssue of Equity
15th Jan 202610:36 amRNSDirector/PDMR Shareholding
15th Jan 202610:35 amRNSDirector/PDMR Shareholding
15th Jan 20269:55 amRNSIssue of Equity
14th Jan 20262:39 pmRNSUnaudited NAV - Dividend Investment Scheme
13th Jan 202612:10 pmRNSUnaudited Net Asset Value
4th Dec 202510:35 amRNSSecond Interim Dividend
18th Nov 20253:48 pmRNSTransaction in Own Shares
14th Nov 20259:31 amRNSNet Asset Value(s)
13th Nov 20254:53 pmRNSResult of General Meeting
2nd Oct 20254:42 pmRNSPublication of a Prospectus
29th Aug 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSIssue of Equity
29th Aug 20257:00 amRNSHalf-year Report
20th Aug 20252:14 pmRNSStatement re Dividend Investment Scheme
31st Jul 20254:42 pmRNSTransaction in Own Shares
16th Jul 202510:18 amRNSStatement re Unaudited NAV and Interim Dividend
16th Jul 20257:08 amRNSStatement re Offer for Subscription
21st May 20254:44 pmRNSTransaction in Own Shares
16th May 20259:30 amRNSDirector/PDMR Shareholding
16th May 20259:26 amRNSIssue of Equity - Dividend Investment Scheme
9th May 20251:53 pmRNSStatement re Dividend Investment Scheme
9th May 202510:03 amRNSNet Asset Value(s)
8th May 20251:43 pmRNSResult of AGM
6th May 202511:55 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.